Pay in 4 interest-free payments of $5.78 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Lancet Diabetes Endocrinol 2021;9:653-62.ArticlePubMed 75
Semaglutide (brand names Ozempic, Wegovy) is used for weight loss, to lower blood sugar levels, and to reduce the risk of major cardiovascular events such as heart attack or stroke in certain patients
A 2022 study published in Diabetes, Obesity and Metabolism found that adults over 50 achieved clinically significant weight loss on semaglutide, with cardiovascular and metabolic risk reductions comparable to younger cohorts, though the authors noted the importance of individualized monitoring protocols for older patients given the higher baseline prevalence of comorbidities
was supported by Programs for Strategic Research Foundation at Private Universities 20112015 and 20132017 supported by the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT), and the Advanced Research and Development Programs for Medical Innovation (AMED-CREST) from Japan Agency for Medical Research and development (AMED)
US$ 23.44
:max_bytes(150000):strip_icc()/health-GettyImages-2025836701-ce3f5ccf0f98428e9d14abaeb07ba307.jpg)
US$ 21.32
US$ 28.11
